Most bought healthcare stocks in Q3 2015
See which Healthcare stocks institutional investors increased the most in Q3 2015, measured as net growth in reported share positions from Q2 2015 into Q3 2015. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), TEVA PHARMACEUTICAL-SP ADR (TEVA), ELEVANCE HEALTH INC (ELV), ABBVIE INC (ABBV). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 50,595,799 | $1.11B | 1 | 4 | 3 | 2 | 9 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 10,371,144 | $568.73M | 1 | 3 | 1 | 0 | 5 |
| ELV | ELEVANCE HEALTH INC | 4,462,298 | $468.54M | 0 | 3 | 3 | 1 | 7 |
| ABBV | ABBVIE INC | 3,901,881 | $181.08M | 0 | 3 | 3 | 2 | 7 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,976,155 | $197.27M | 0 | 6 | 3 | 0 | 10 |
| BKD | BROOKDALE SENIOR LIVING INC | 2,749,607 | $22.25M | 0 | 2 | 0 | 0 | 2 |
| JNJ | JOHNSON & JOHNSON | 1,892,028 | $89.25M | 1 | 7 | 8 | 0 | 20 |
| MCK | MCKESSON CORP | 1,625,114 | $253.57M | 0 | 1 | 1 | 1 | 2 |
| DHR | DANAHER CORP | 1,538,413 | $100.11M | 1 | 3 | 2 | 1 | 7 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,518,300 | -$77.16M | 0 | 1 | 0 | 0 | 2 |
| DVA | DAVITA INC | 1,379,154 | -$281.81M | 0 | 3 | 2 | 0 | 6 |
| RMD | RESMED INC | 1,361,000 | $69.36M | 1 | 0 | 0 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | 1,300,279 | -$110.52M | 0 | 6 | 4 | 1 | 13 |
| AMGN | AMGEN INC | 924,894 | -$46.32M | 1 | 4 | 3 | 0 | 8 |
| WAT | WATERS CORP | 906,932 | $88.47M | 0 | 4 | 0 | 0 | 4 |
| ARAY | ACCURAY INC | 866,071 | $2.35M | 0 | 1 | 0 | 0 | 1 |
| CNC | CENTENE CORP | 830,400 | $17.08M | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 786,230 | -$150.51M | 1 | 4 | 4 | 2 | 10 |
| CAH | CARDINAL HEALTH INC | 755,238 | $56.44M | 1 | 2 | 1 | 0 | 4 |
| HUM | HUMANA INC | 688,392 | $82.84M | 0 | 2 | 0 | 1 | 2 |
| IDXX | IDEXX LABORATORIES INC | 591,942 | $47.24M | 0 | 1 | 1 | 0 | 3 |
| CVS | CVS HEALTH CORP | 580,723 | -$14.32M | 2 | 2 | 4 | 1 | 10 |
| SGMO | SANGAMO THERAPEUTICS INC | 578,655 | $2.68M | 1 | 1 | 0 | 0 | 2 |
| BLUE | BLUEBIRD BIO INC | 569,957 | $44.98M | 1 | 0 | 0 | 1 | 1 |
| RVTY | REVVITY INC | 322,800 | $14.38M | 0 | 1 | 0 | 0 | 1 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 314,318 | $4.29M | 0 | 1 | 0 | 0 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 276,300 | $6.81M | 0 | 1 | 0 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | 232,500 | $15.70M | 0 | 2 | 0 | 0 | 2 |
| NEOG | NEOGEN CORP | 224,143 | $9.96M | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 218,516 | $27.50M | 1 | 1 | 2 | 0 | 5 |
| HAE | HAEMONETICS CORP/MASS | 213,700 | $6.49M | 0 | 1 | 0 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 212,560 | $7.32M | 0 | 1 | 0 | 0 | 1 |
| INGN | INOGEN INC | 194,377 | $10.33M | 0 | 1 | 0 | 0 | 1 |
| ITCI | INTRA-CELLULAR THERAPIES INC | 183,091 | $7.33M | 1 | 0 | 0 | 0 | 1 |
| UTHR | UNITED THERAPEUTICS CORP | 177,127 | -$29.65M | 0 | 2 | 0 | 0 | 2 |
| PINC | PREMIER INC-CLASS A | 173,100 | $5.41M | 0 | 1 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 168,597 | $3.35M | 0 | 2 | 0 | 0 | 2 |
| CTLT | CATALENT INC | 163,318 | $3.01M | 0 | 1 | 0 | 0 | 1 |
| PBYI | PUMA BIOTECHNOLOGY INC | 162,600 | $12.25M | 1 | 0 | 0 | 0 | 1 |
| LAB | STANDARD BIOTOOLS INC | 161,512 | $1.31M | 1 | 0 | 0 | 0 | 1 |
| SEM | SELECT MEDICAL HOLDINGS CORP | 160,322 | $1.73M | 1 | 0 | 0 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | 159,900 | $5.11M | 0 | 1 | 0 | 0 | 1 |
| XNCR | XENCOR INC | 150,353 | $1.84M | 1 | 0 | 0 | 0 | 1 |
| CYTK | CYTOKINETICS INC | 147,300 | $983.00K | 0 | 1 | 0 | 0 | 1 |
| PETS | PETMED EXPRESS INC | 146,215 | $450.00K | 0 | 1 | 0 | 0 | 1 |
| GMED | GLOBUS MEDICAL INC - A | 143,945 | $2.97M | 1 | 0 | 0 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 139,100 | $6.26M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 136,550 | $3.25M | 0 | 1 | 1 | 0 | 2 |
| OSUR | ORASURE TECHNOLOGIES INC | 135,296 | -$740.00K | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 130,641 | $5.20M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2015
What are the most bought Healthcare stocks in Q3 2015?
The most bought healthcare stocks in Q3 2015 are those with the largest increase in reported share counts across institutional investors compared to Q2 2015, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2015?
Among filers in this sector, net additions were largest in companies such as BAXTER INTERNATIONAL INC (BAX), TEVA PHARMACEUTICAL-SP ADR (TEVA), ELEVANCE HEALTH INC (ELV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2015).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.